Ethical Questions Emerge Over Who Gets The 'Ebola Drug'

Ethical Questions Emerge Over Who Gets The 'Ebola Drug'
In this photo provided by the Spanish Defense Ministry, aid workers and doctors transfer Miguel Pajares, a Spanish priest who was infected with the Ebola virus while working in Liberia, from a plane to an ambulance as he leaves the Torrejon de Ardoz military airbase, near Madrid, Spain, Thursday, Aug. 7, 2014. A Spanish missionary priest who tested positive for the Ebola virus was in stable condition at a Madrid hospital on Thursday after being evacuated from Liberia, health officials said. (AP Photo/Spanish Defense Ministry,)
In this photo provided by the Spanish Defense Ministry, aid workers and doctors transfer Miguel Pajares, a Spanish priest who was infected with the Ebola virus while working in Liberia, from a plane to an ambulance as he leaves the Torrejon de Ardoz military airbase, near Madrid, Spain, Thursday, Aug. 7, 2014. A Spanish missionary priest who tested positive for the Ebola virus was in stable condition at a Madrid hospital on Thursday after being evacuated from Liberia, health officials said. (AP Photo/Spanish Defense Ministry,)

In a development that raises a host of ethical issues, Spain announced it had obtained a scarce U.S.-made experimental Ebola drug to treat a Spanish missionary priest infected with the killer virus.

The Health Ministry statement came less than a week after the U.S. Centers for Disease Control and Prevention said there were virtually no doses available of the drug that was used to treat two Americans with the disease.

Popular in the Community

Close

HuffPost Shopping’s Best Finds

MORE IN LIFE